Used by doctors, coders, health information managers, nurses, and other healthcare workers, ICD-11 is more granular aligning classification with the latest knowledge of disease treatment and prevention, thus making it more meaningful than ICD10
Like GLP-1 medications, co-agonists can lower blood sugar
Open Source Softw
Community Experiences: Real-World Reports The Microdosing Movement Online communities have emerged around GLP-1 microdosing: Reddit r/Peptides: 1,700+ members discussing microdosing strategies Facebook groups: Multiple private groups with thousands of members TikTok trends: #GLP1Hack videos with millions of views Discord servers: Real-time support and protocol sharing Reported Motivations 66% Side effect reduction 38% Cost savings 28% Better control of blood sugar Common Protocols Reported While not medically validated, community members report using: Monday/Thursday: Twice-weekly splitting for convenience Monday/Wednesday/Friday: Three times weekly for stability Every other day: Maximum smoothing of levels Variable dosing: Higher doses on less active days Concerning Trends Problematic behaviors observed: 55% make decisions without physician consultation Many use compounded medications of uncertain quality Dose escalation beyond FDA-approved limits Combining multiple GLP-1 agonists Following influencer protocols without medical oversight A Personal Perspective When I started reading the reta research, one thing bugged me: this triple-agonist mechanism is far more complex than semaglutide, yet the dosing protocol is identical: once weekly, same as everything else
That is the main reason a shot tends to act faster than a tablet
*Correspondence: Lu Zhang, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
